GMP should tick up the SP in the short term - maybe get it above 7 cents anyway and we can hope for some revenue from the DEMA division deals but I agree that a CR is inevitable now = perhaps in the next 12 months. GMP should generate more MM deals and that should help. Even if the VC deal is resurrected - the damage has already been done regarding cash levels. Real pity. If the cash had come in over the last 8 months that the deal would have generated then MXC's cashflow would have been very healthy. The real reason there has been no legal action to seek damages is that MXC lacks the cash to initiate action - a dilemma for MXC management I suspect.
MXC Price at posting:
6.3¢ Sentiment: Buy Disclosure: Held
